University of South Florida | ARC Portal Login
  Help
 

Basic Folder Information

Additional Information

Effective October 1, 2014 industry-sponsored clinical trials will be reviewed by either Western IRB (WIRB), Schulman Associates IRB, or Quorum Review IRB.

The USF IRB will only review FDA regulated research for investigator initiated studies and research requiring review by the USF Biosafety Committee (i.e., studies involving recombinant DNA). Please see https://www.usf.edu/research-innovation/research-integrity-compliance/ric-programs/irb/irb-hrpp/additional-information/single-irb.aspx for additional information and details.

USF investigators are encouraged to use the Johns Hopkins Medicine All Children's Hospital (ACH) IRB for studies that will be conducted with ACH patients and/or at ACH or ACH and USF sites. This will prevent submission of applications to both IRBs as the USF IRB can rely upon the approval of the ACH IRB.  Depending on the level of risk, there may be studies that require both ACH IRB and USF IRB approval, which will be determined by the ACH IRB.

The ACH IRB uses iRIS for electronic submission of all IRB applications. Training is required prior to using iRIS. To register for the iRIS training please contact Sue Ellie, (727) 767-4275 or sue.ellie@allkids.org. To register for iRIS please contact Sandy Wismer, (727) 767-4813 or sandy.wismer@allkids.org.

Footer Wrapper